MOMA Therapeutics Revenue and Competitors

Boston, MA USA

Location

$86M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • MOMA Therapeutics's estimated annual revenue is currently $13M per year.(i)
  • MOMA Therapeutics's estimated revenue per employee is $155,000
  • MOMA Therapeutics's total funding is $86M.

Employee Data

  • MOMA Therapeutics has 84 Employees.(i)
  • MOMA Therapeutics grew their employee count by 1% last year.

MOMA Therapeutics's People

NameTitleEmail/Phone
1
Founder and FellowReveal Email/Phone
2
President and CEO at MOMA TherapeuticsReveal Email/Phone
3
Executive Assistant to the CEOReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
Chief People and Experience OfficerReveal Email/Phone
6
SVP, Drug DiscoveryReveal Email/Phone
7
VP Strategic FinanceReveal Email/Phone
8
SVP, Head Data SciencesReveal Email/Phone
9
VP Research Strategy and OperationsReveal Email/Phone
10
VP, Head, Nonclinical/CMC DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13M841%$86MN/A
Add Company

What Is MOMA Therapeutics?

Weᅢᄁ¬ツᆲ¬トᄁre on a mission to unlock molecular machines by understanding and respecting their complexities. Weᅢᄁ¬ツᆲ¬トᄁll be working incredibly hard to discover their untapped potential because we believe they are the key to delivering the next generation of precision medicines. We are unapologetically scientific, and we know this will help us achieve our mission to get new medicines to people in need. Weᅢᄁ¬ツᆲ¬トᄁve removed the bureaucracy and believe having a teammateᅢᄁ¬ツᆲ¬トᄁs back is critical to our success. You see, MOMA isnᅢᄁ¬ツᆲ¬トᄁt your typical biotech company. We are drug discovery professionals, industry specialists and scientific experts. More importantly, weᅢᄁ¬ツᆲ¬トᄁre collectively unstoppable.

keywords:N/A

$86M

Total Funding

84

Number of Employees

$13M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.8M84-12%N/A
#2
$12.6M845%N/A
#3
$11.8M841%N/A
#4
$3.5M845%N/A
#5
$22.7M84-9%N/A